Mar 13, 2024 / 08:30PM GMT
Operator
Good afternoon, and welcome to the Spero Therapeutics full year 2023 financial results conference call. (Operator Instructions) Please be advised that this call is being recorded and a replay will be available. You can find information on the replay and further information related to today's announcement on the Spero Therapeutics website at www.sperotherapeutics.com. At this time, I would like to turn the call over to Michael Wood, Managing Director at LifeSci Advisors. Mr. Woods, please go ahead.
Michael Wood - LifeSci Advisors, LLC. - Investor Relations
Thank you, operator, and thank you all for participating in today's conference call. This afternoon, Spero Therapeutics released financial results and provided a business update for the fourth quarter and full year 2023. The press release is available on our Investors page of the Spero Therapeutics website.
Before I begin, I'd like to remind you that some of the information presented in this conference call contains forward
Q4 2023 Spero Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot